猪圆环病毒2型Cap蛋白在大肠杆菌中的可溶性表达及在小鼠体内免疫特性研究

doi:10.13523/j.cb.20160408

中国生物工程杂志

2016, Vol. 36

Issue (4): 50-56 DOI: 10.13523/j.cb.20160408

研究报告

猪圆环病毒2型Cap蛋白在大肠杆菌中的可溶性表达及在小鼠体内免疫特性研究

刘盼娆, 周雪晨, 朱雪蛟, 白娟, 王先炜, 姜平

南京农业大学动物医学院南京 210095

The Soluble Expression of Porcine Circovirus Type 2 Cap Gene in Escherichia coli and Its Immunogenicity in Mice

LIU Pan-rao, ZHOU Xue-chen, ZHU Xue-jiao, BAI Juan, WANG Xian-wei, JIANG Ping

College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China

全文: PDF(1435 KB) HTML

摘要：

猪圆环病毒2型(PCV2)Cap蛋白基因是该病毒基因工程疫苗的重要目的基因,但其在大肠杆菌表达系统中的表达产物通常以包涵体形式存在,影响其作为亚单位疫苗使用的免疫保护作用。将ORF2基因密码子改造为大肠杆菌偏爱的密码子,或构建MPG与ORF2基因融合,分别克隆至表达载体pET28a,再转化至大肠杆菌BL21(DE3),经IPTG诱导表达。SDS-PAGE和Western blot结果证实改造后的PCV2 Cap蛋白基因实现了可溶性表达。将上述两种重组蛋白纯化后,分别与GEL01、ISA206或ISA15A三种佐剂混合配制疫苗,小鼠免疫保护试验结果证明,以GEL01为佐剂的两免疫组PCV2 ELISA抗体和中和抗体水平最高。攻毒试验结果显示,除ISA15A组外,其他各免疫组脾脏中 PCV2 含量都显著低于非免疫对照组,表明两种重组蛋白与佐剂GEL01和ISA206制成的疫苗可诱导产生一定水平的免疫保护作用,为PCV2亚单位疫苗的研制奠定了基础。

关键词： Cap蛋白; 可溶性表达; PCV2; 免疫特性

Abstract:

Porcine circovirus type 2(PCV2)Cap gene has been used as target gene for developing genetic engineering vaccine. However, it is usually expressed as the form of inclusion body in E.coli which having low protective efficacy against PCV2 challenge. The PCV2 ORF2 gene condons was optimized and fused with MPG gene. Then, they were cloned into expression vector pET28a and induced for expression in E.coli BL21(DE3) individually. SDS-PAGE and Western blot results confirmed that they could be expressed with the production of soluble proteins. After purification, the two kinds of proteins were mixed with GEL01, ISA206 and ISA15A adjuvant respectively. Mice experiment results showed that the GEL01 groups induced the highest levels of antibodies against PCV2 with ELISA and neutralization antibody assay. Following challenge with PCV2, the PCV2 virus loads in spleen in immunized groups except the ISA15A were significantly lower than challenge control group. It indicated that the vaccine prepared by the two recombinant proteins and GEL01 and ISA206 could induce immune protection in mice against PCV2 infection, which laid a foundation for the development of PCV2 subunit vaccine.

Key words: Cap protein PCV2 Soluble expression Immunogenicity

收稿日期: 2015-10-12 出版日期: 2016-01-04

ZTFLH:

Q789

基金资助:

农业部行业专项子项目(201203039)、国家生猪产业技术体系专项(CARS-36)、江苏省科技支撑计划(BE2012368)、江苏省教育厅产业发展项目(JH09-1)资助项目

通讯作者: 姜平 E-mail: jiangp@njau.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘盼娆
	周雪晨
	朱雪蛟
	白娟
	王先炜
	姜平

引用本文:

刘盼娆, 周雪晨, 朱雪蛟, 白娟, 王先炜, 姜平. 猪圆环病毒2型Cap蛋白在大肠杆菌中的可溶性表达及在小鼠体内免疫特性研究[J]. 中国生物工程杂志, 2016, 36(4): 50-56.

LIU Pan-rao, ZHOU Xue-chen, ZHU Xue-jiao, BAI Juan, WANG Xian-wei, JIANG Ping. The Soluble Expression of Porcine Circovirus Type 2 Cap Gene in Escherichia coli and Its Immunogenicity in Mice. China Biotechnology, 2016, 36(4): 50-56.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20160408 或 https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I4/50

[1] Ellis J, Hassard L, Clark E, et al. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J, 1998, 39(1): 44-51.
[2] Opriessnig T, Meng X J, Halbur P G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Invest, 2007, 19(6): 591-615.
[3] Baekbo P, Kristensen C S, Larsen L E. Porcine circovirus diseases: a review of PMWS.Transbound Emerg Dis,2012, 59 (Suppl. 1):60-67.
[4] Hamel A L, Lin L L, Nayar G P. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol, 1998, 72(6): 5262-5267.
[5] Lv Q Z, Guo K K, Han X, et al. Identification of putative ORF5 protein of porcine circovirus type 2 and functional analysis of GFP-fused ORF5 protein. PLoS One,2015, 10(6): e0127859.
[6] Zhang H W, Qian P, Liu L F, et al. Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes. Viruses-Basel, 2014, 6(12): 4839-4855.
[7] 解庭波. 大肠杆菌表达系统的研究进展. 长江大学学报, 2008,5(3):77-82 Xie T B. The research progress of E.coli expression system . Journal of Yangze University(Natural Science Edition), 2008,5(3):77-82.
[8] Trundova M, Celer V. Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells. Virus Genes, 2007, 34(2):199-204.
[9] Wu P C, Lin W L, Wu C M, et al. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol, 2012, 95(6): 1501-1507.
[10] Liu Q, Willson P, Attoh-Poku S, et al. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Expression and Purification, 2001, 21(1): 115-120.
[11] Bucarey S A, Noriega J, Reyes P, et al. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine, 2009, 27(42): 5781-5790.
[12] Morris M C, Vidal P, Chaloin L, et al. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Research, 1997,25(14): 2730-2736.
[13] Jrver P, Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today, 2004,9(9):395-402.
[14] Moschos S A, Jones S W, Perry M M, et al. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjugate Chemistry, 2007, 18(5): 1450-1459.
[15] Joliot A. Transduction peptides within naturally occurring proteins. Sci Stke, 2005, 2005(313):54.
[16] 朱琳,刘兰霞,宋丽萍,等. LHRH-MPG^△NLS/siRNA纳米复合物的制备及稳定性观察. 生物医学工程与临床,2012,16(3): 283-285. Zhu L, Liu L X, Song L P, et.al. Study on the method for preparing stable LHRH-MPG^△NLS/siRNA nanoparticles. Biomedical Engineering and Clinical Medicine,2012,16(3): 283-285.
[17] 吕慧,王先炜,李文良,等. 猪圆环病毒2型重组Cap蛋白间接ELISA抗体检测方法的建立. 畜牧与兽医,2009,41(11): 6-11. Lv H, Wang X W, Li W L, et.al. Development of an indirect ELISA for detecting antibody to porcine circovirus 2 using recombinant Cap protein. Animal Husbandry & Veterinary Medicine, 2009,41(11):6-11.
[18] 冯志新,姜平,王先炜,等.猪圆环病毒 2 型 TaqMan 实时 PCR 检测方法的建立. 中国病毒学,2006, 1(4): 371-374. Feng Z X, Jiang P, Wang X W, et al. Development of a real-time PCR method for detection of type 2 porcine circovirus. Virology Sinica, 2006,21(4):371-374.
[19] Beach N M, Meng X J. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res, 2012, 164(1-2): 33-42.

[1]	邓通,周海胜,吴坚平,杨立荣. 基于分子伴侣策略提高NADPH依赖型醇脱氢酶的异源可溶性表达 ^*[J]. 中国生物工程杂志, 2020, 40(8): 24-32.
[2]	许敏华,张晶晶,金小宝,李小波,王艳,马艳. 美洲大蠊内生菌几丁质酶基因的克隆、表达及其活性研究 ^*[J]. 中国生物工程杂志, 2019, 39(1): 31-37.
[3]	冀君, 朱晨晨, 许鑫, 刘晓, 冷超粮, 史鸿飞, 姚伦广, 阚云超. 鸡贫血病毒凋亡素基因的可溶性融合表达及抗肿瘤活性分析[J]. 中国生物工程杂志, 2017, 37(2): 26-32.
[4]	张宇萌, 童梅, 陆小冬, 米月, 徐晨, 姚文兵. 提高大肠杆菌可溶性重组蛋白表达产率的研究进展[J]. 中国生物工程杂志, 2016, 36(5): 118-124.
[5]	路青山, 乔媛媛, 李金凤, 王运良, 王姗姗, 史成和, 杨霄鹏, 张达矜. 人HPPCn重组蛋白可溶性表达及其增殖活性检测[J]. 中国生物工程杂志, 2015, 35(12): 15-20.
[6]	张超, 巩蔚, 郭莹莹, 孙卫国, 姚敏, 于爱平. 重组抗凝蛋白-新蛭素的原核表达研究[J]. 中国生物工程杂志, 2014, 34(12): 69-77.
[7]	韩翠晓, 李锋, 严孝金, 冯舵, 李倩倩, 高宏波, 高伟. 叶绿体分裂蛋白PDV1胞质侧结构域可溶性表达条件的研究及纯化[J]. 中国生物工程杂志, 2012, 32(6): 35-42.
[8]	李倩倩, 李中媛, 冯舵, 黄火清, 韩翠晓, 杨培龙, 姚斌, 高伟. 芽孢杆菌β-折叠桶植酸酶的原核可溶性表达优化及包涵体复性研究[J]. 中国生物工程杂志, 2012, 32(08): 49-55.
[9]	何红秋, 贾渝跃. HIV-1整合酶核心区可溶性表达及抑制剂筛选[J]. 中国生物工程杂志, 2012, 32(03): 14-19.
[10]	胡熔, 刘大岭, 谢春芳, 姚冬生. 黄曲霉毒素解毒酶在大肠杆菌中的可溶性表达、纯化及其圆二色谱分析[J]. 中国生物工程杂志, 2011, 31(04): 71-76.
[11]	李江姣, 朱武洋, 何英, 梁国栋. 辛德毕斯病毒E2包膜蛋白可溶性表达条件的优化[J]. 中国生物工程杂志, 2011, 31(02): 62-68.
[12]	杨东刘斌何红秋张小轶张海锋许先进陈慰祖王存新. T66I突变提高HIV-1整合酶可溶性研究[J]. 中国生物工程杂志, 2010, 30(08): 17-21.
[13]	汪洋,马明浩,冯震,吴叶林,张绪瑛,金明飞,黄静,吴自荣. 重组人谷氨酸脱羧酶65的表达及活性研究[J]. 中国生物工程杂志, 2009, 29(04): 12-16.
[14]	张守涛,周雁胜,包星峰,郭蔼光. 蛇毒纤溶酶Alfimeprase在大肠杆菌中的可溶表达和纯化[J]. 中国生物工程杂志, 2006, 26(03): 31-36.
[15]	金宁一, 秦晓冰, 郑敏, 鲁会军, 张洪勇, 尹革芬, 葛淑敏. 猪2型圆环病毒核酸疫苗的接种Balb/c小鼠实验免疫研究[J]. 中国生物工程杂志, 2005, 25(7): 76-79.

Viewed

Full text

Abstract

Cited

Shared

Discussed